The global Pruritus Therapeutics Market was estimated at USD 12.11 billion in 2021 and is projected to reach USD 16.37 billion by 2028, growing at a CAGR of 4.4% over the analysis period.
Pruritus also known as dry skin is a common cause of itchy skin. It's more frequent in older people since their skin dries out with age. Antibiotics, antifungals, anticonvulsants, and a few natural remedies such as topical application of coconut oil, vitamin E, and honey are utilized to treat pruritus. Itchy skin is an uncomfortable, annoying sensation that causes individuals to scratch. It is more common in the elderly because their skin dries out with age. The skin may appear normal, red, rough, or streaked, depending on the cause of the itching. Repeated scratching can result in raised, thickened skin that may bleed or become infected. Many people find relief from self-care methods such as frequent moisturizing, gentle cleansers, and tepid showers. Long-term relief requires identifying and treating the source of the skin itch.
Read Full Research Report:
The Pruritus Therapeutics Market Research report includes value chain analysis for each type of product. Value chain analysis provides in-depth information about adding value at each stage. The study includes the drivers and constraints of the Pruritus Therapeutics Market along with their impact on demand during the forecast period. The study also provides key market indicators that influence market growth.
Top Key Players Covered In Pruritus Therapeutics Market:
- AbbVie Inc.
- Sanofi SA
- Galderma Laboratories LP
- EPI Health LLC
- Cara Therapeutics
- Trevi Therapeutics
- Novartis AG
- Pfizer Inc.
- Merck & Co. Inc.
- Sun Pharmaceuticalc
- Glenmark Pharmaceuticals Ltd.
- Abbott Laboratories, and Other Major Players.
Get PDF Sample Report Of Pruritus Therapeutics Market:
Segmentation Analysis Of Pruritus Therapeutics Market:
By Drug Class:
The corticosteroids segment is anticipated to lead the growth of the pruritus therapeutics market over the projected period. Over the last 40 years, topical corticosteroids have been the mainstay of atopic dermatitis treatment.
By Disease Type:
The atopic dermatitis segment is expected to have the highest share of the pruritus therapeutics market in the forecasted period. Atopic Dermatitis (AD), also known as eczema, is a common inflammatory skin condition.
By Route Of Administration:
The topical segment is expected to have the highest share of the pruritus therapeutics market in the analysis period. In recent years, there has been a significant increase in the use of topical medications.
By Drug Class:
- Calcineurin Inhibitors
By Disease Type:
- Allergic Contact Dermatitis
- Atopic Dermatitis
For More Information Or Any Query Visit@:
Regional Analysis Of Pruritus Therapeutics Market:
The North American region is anticipated to dominate the pruritus therapeutics market over the forecasted period attributed to the growing prevalence of chronic diseases such as diabetes, eczema, and other skin-related disorders. According to the National Eczema Association, 31.6 million Americans (10.1%) have some form of eczema, with prevalence peaking during childhood.
- North America (U.S., Canada, Mexico)
- Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)
- Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)
- Middle East & Africa (Turkey, Saudi Arabia, Iran, UAE, Africa, Rest of MEA)
- South America (Brazil, Argentina, Rest of SA)
COVID-19 Impact on Pruritus Therapeutics Market:
The impact of COVID-19 on the Atopic Dermatitis (AD) population remains unclear. The rapid spread of the COVID-19 pandemic has negatively affected many aspects of daily life. In terms of disease prevention, preventive measures such as social distancing and hand hygiene habits, as well as patient education, have been a top priority. The intense and persistent stress involved in dealing with a chronic skin problem, along with the risk of contracting COVID-19, increases patients' anxiety. Although SARS-CoV-2 is mostly responsible for respiratory problems rather than skin diseases, it has a significant impact on patients with skin diseases and conditions.
Scope Of The Report:
Market size available for years
Base year considered
Type, Application, and Region
North America, APAC, Europe, MEA, and Latin America
Reasons To Buy The Report:
- To identify the main subsegments of the Pruritus Therapeutics market to comprehend its structure.
- Identifies describes, and analyses the sales volume, value, market share, competitive market landscape, opportunities and threats, and strategic initiatives for the main worldwide Pruritus Therapeutics manufacturers for the next few years.
- To examine the Pruritus Therapeutics in terms of specific expected growth, career outlook, and market share contribution.
- Analyze commercial developments in the market, such as market expansions, partnerships, new product development, and mergers.
- To develop a strategic analysis of the main players and a thorough analysis of their strategic planning.
Buy the Latest Version of Report:
Read More Reports:
Introspective Market Research (introspectivemarketresearch.com) is a visionary research consulting firm dedicated to assist our clients grow and have a successful impact on the market. Our team at IMR is ready to assist our clients flourish their business by offering strategies to gain success and monopoly in their respective fields. We are a global market research company, specialized in using big data and advanced analytics to show the bigger picture of the market trends. We help our clients to think differently and build better tomorrow for all of us. We are a technology-driven research company, we analyze extremely large sets of data to discover deeper insights and provide conclusive consulting. We not only provide intelligence solutions, but we help our clients in how they can achieve their goals.
Introspective Market Research
3001 S King Drive,
Ph no: +1-773-382-1047